Kristen Krysko, MD, suggests that modern fertility treatments and appropriately timed disease-modifying therapies may not ...
Patients with multiple sclerosis receiving chronic ocrelizumab treatment may develop hypogammaglobulinemia and experience ...
The absolute number of multiple sclerosis deaths in the United States increased significantly between 1999 and 2020.
Tocilizumab may offer more consistent relapse suppression than rituximab in MOGAD, though pooled estimates do not establish ...
High baseline fatigue and depression scores can predict a persistently high fatigue burden over time in secondary progressive ...
Among women with multiple sclerosis receiving ofatumumab, postmenopausal status is linked to higher disability scores and ...
The Food and Drug Administration (FDA) has granted Fast Track designation to AV-1959R for the prevention of Alzheimer disease in cognitively unimpaired individuals with biomarker evidence of amyloid ...
Women with endometriosis have more than twice the odds of migraine, but short-term billing records may substantially underestimate the overlap.
Osteoporosis screening remains underutilized among women with multiple sclerosis, pointing to an urgent need for targeted ...
Stopping disease-modifying therapy in patients with multiple sclerosis is linked to higher disability scores and disease ...
An increased risk for autism spectrum disorder and intellectual disability appear to be associated with congenital TORCH infections.
Even with advanced directives requestion life-sustaining treatment, many surrogates are less likely to choose LST for patients with dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results